Skip to main content

Choosing a first MS treatment brought fear and doubt

By MS Buddy ·

Summarized from Qualitative health research, Nov 2026 · PubMed · DOI. AI-generated summary. Not medical advice.

17 people newly diagnosed with MS involving relapses and periods of recovery

Research by Eva van Reenen, Leo Visser and 3 colleagues at the University of Humanistic Studies and Drew University in the Netherlands and the United States.

How do people with newly diagnosed MS experience choosing their first treatment?

Key Takeaway

Choosing a first MS treatment involved fear, doubt, and uncertainty about both future disability and whether treatment would work.

A myelin-wrapped nerve fiber beside branching paths that continue beyond view, with no preferred route marked.
Credibility
Interest
Share:1 min read

What They Found

Participants described choosing treatment as a difficult journey marked by fear, doubt, and responsibility. They faced uncertainty about both how MS would develop and how well treatment would work. Some sought the safest option, while others felt confused, disappointed, or in need of clearer explanations. Participants managed uncertainty by building personal stories, trusting doctors, or accepting what they could not control. Their experiences suggested that treatment decisions involved emotions and relationships, not just weighing facts and preferences.

Who Should Care and Why

The study involved people recently diagnosed with relapsing-remitting MS (MS with flare-ups followed by periods of recovery). They were choosing their first medicine intended to change the course of MS. Their care emphasized shared decision making (patients and healthcare professionals making treatment choices together). The findings describe how difficult these choices felt even when patients were involved in decisions. They highlight the role of trust, personal meaning, and ongoing support when treatment outcomes remain uncertain.

Important Considerations

This study analyzed interviews with 17 people recently diagnosed with MS. It explored their experiences rather than comparing treatments or measuring how well medicines worked. It does not show whether a different approach to treatment decisions would improve health outcomes.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Qualitative health research by et al.. Reproduced from the PubMed record.

People with relapsing-remitting multiple sclerosis (RRMS) face complex choices among various disease-modifying therapies (DMTs), each marked by uncertain outcomes. Shared decision making (SDM) is increasingly promoted to support such treatment decisions, yet how people experience choosing a DMT under inherent uncertainty within this context remains underexplored. This study examines how people with RRMS experience the initial choice for a DMT under inherent uncertainty within an SDM-framed healthcare context. A phenomenological-hermeneutic approach was adopted, involving interviews with 17 participants recently diagnosed with RRMS. Analysis reveals six experiential pathways: making the safer bet, facing confusion and disappointment, longing for clarity and understanding, constructing a narrative, relinquishing control, and putting in the work. Participants experience the decision as an arduous journey marked by fear, doubt, and responsibility. They grapple with 'double uncertainty' regarding both disease progression and treatment effectiveness. While SDM typically frames decision making as a rational weighing of evidence and preferences, participants experience treatment decisions as precarious, emotionally charged, and relationally embedded. Rather than eliminating uncertainty, they seek to reconcile with it by constructing narratives, trusting physicians, or surrendering to what cannot be controlled. These findings challenge a narrow view of SDM as a rational, individual act based on clear-cut evidence and stable preferences. They point to the need for a broader understanding of SDM as a relational, iterative practice, in which uncertainty is a moral and existential condition of care. This requires acknowledging uncertainty as part of care and supporting patients in integrating medical choices into meaningful, evolving life narratives.

Categories

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

Nerve fibers with segmented myelin coverings, including a few areas where the covering is missing.
MS rates varied widely across North and South America

11/19/2026

A review of 50 studies found wide differences in MS rates across the Americas. MS became more common

Read More
Two clusters of paper speech bubbles contain varied patchwork shapes on one side and orderly layers on the other.
MS side effect posts showed two communication styles

11/20/2026

A study of online MS medication discussions found two main styles: sharing personal experiences and

Read More
Paper vegetables and a walking shoe beside unfinished paths that stop short of a cluster of cell-like circles.
MS review: diet and exercise links need more evidence

11/18/2026

A review finds limited direct evidence that diet, exercise, or gut microbes affect MS through the bo

Read More
Immune cells beside a myelin-covered nerve fiber, with branching paths suggesting varied immune effects.
Pregnancy may affect MS and other diseases differently

11/18/2026

This review explores how pregnancy may affect MS and other diseases involving immune attacks on the

Read More
Two paper paths meet at an open junction, surrounded by layered shapes in muted colors.
When older adults with MS should stop drugs remains unclear

11/15/2026

A survey of 24 Israeli MS specialists found agreement on weighing more than age when treating older

Read More
A navy blood drop holds two clusters of small rust-colored shapes on a plain background.
People with MS had higher blood mercury and chromium

11/12/2026

A blood study found higher mercury and chromium, but lower aluminum and titanium, in people with MS

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.